(Total Views: 497)
Posted On: 03/26/2025 12:07:55 AM
Post# of 151512
Quote:
If the RECOVER-TLC team declines to include leronlimab, we will resume the pursuit of a pilot study in patients with ME/CFS, for which we already have a draft protocol synopsis and lead investigator identified.
Due to recent idiotic events, NIH funding for numerous new trials is up in the air.
(8)
(0)Scroll down for more posts ▼
